Study of a curcumin insert for vaginal infection
Part of Infections, Women’s health & pregnancy clinical trials.
This trial tests a vaginal insert containing curcumin for treating bacterial vaginosis or a yeast infection. You may qualify if you have symptoms and a lab-confirmed diagnosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a lab-confirmed bacterial vaginosis or vaginal yeast infection.
- You must be having symptoms of the infection.
- You must not have started a cream or pill for the infection within the past 7 days.
- You must not be using other vaginal products (like rings or diaphragms).
- You must not be pregnant or planning to become pregnant.
- You must not have taken steroids or other immune-suppressing medicines in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a vaginal ovule (a small insert) medical device to treat bacterial vaginosis and yeast infections. It aims to see if the device is safe and effective at relieving symptoms like discharge, itching, and burning.
This trial tests a new live biotherapeutic product (a kind of probiotic) to treat bacterial vaginosis or yeast infections. It compares different doses to see which works best and is safest for relieving symptoms.
This trial tests a vaginal gel to treat and prevent common vaginal infections like yeast infections (VVC) and bacterial vaginosis (BV). It may help if you currently have symptoms like itching, discharge, or odor.
This trial tests a single dose of an investigational drug given vaginally to healthy Chinese women. It aims to see if the drug is safe and how the body processes it.
This study tests a new vaginal gel for bacterial vaginosis (BV) in women aged 18-50. It aims to see if the gel is safe and works better than current treatments.
This trial tests a combination of BPR-101 capsules (a probiotic) and an antibiotic (metronidazole) for women with bacterial vaginosis (BV). The goal is to see if this combination is more effective and safe than standard treatment alone.
Hear when a new Bacterial Vaginosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.